← Holders
Integral Health Asset Management, LLC
What Integral Health Asset Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1773206 · Filed Nov 16, 2026
- Positions
- 97
- Reported value
- $1.6B
- Opened
- 40
- Closed
- 35
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$1.5B76 positions
- Dec 31, 2025$2B86 positions
- Mar 31, 2026$2.1B90 positions
- Jun 30, 2026$2.5B92 positions
- Sep 30, 2026$1.6B97 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
RVMDRevolution Medicines, Inc. | 1M | −33.3% | $130.3M | 7.9% |
INSMInsmed Inc | 1.6M | ±0% | $129M | 7.8% |
EWTXEdgewise Therapeutics, Inc. | 2.4M | +20.0% | $97.4M | 5.9% |
CYTKCytokinetics Inc | 1.6M | ±0% | $72.5M | 4.4% |
MRKMerck & Co., Inc. | 450K | +28.6% | $65.4M | 4% |
SRRKScholar Rock Holding Corp | 1.3M | +67.3% | $60.6M | 3.7% |
CNCCentene Corp | 750K | +150.0% | $46.6M | 2.8% |
AXSMAxsome Therapeutics, Inc. | 250K | −16.7% | $46.1M | 2.8% |
VERAVera Therapeutics, Inc. | 1.5M | −14.3% | $32.3M | 2% |
AMGNAmgen Inc | 75K | New | $31.6M | 1.9% |
LFSTLifeStance Health Group, Inc. | 2.6M | −13.3% | $31.3M | 1.9% |
REGNRegeneron Pharmaceuticals, Inc. | 40K | ±0% | $30.3M | 1.8% |
THCTenet Healthcare Corp | 90K | −45.5% | $23M | 1.4% |
BIIBBiogen Inc. | 100K | ±0% | $22.6M | 1.4% |
TNGXTango Therapeutics, Inc. | 1M | ±0% | $22.5M | 1.4% |
CAHCardinal Health Inc | 100K | −66.7% | $22.3M | 1.4% |
CVSCVS Health Corp | 500K | −54.5% | $21.4M | 1.3% |
NBIXNeurocrine Biosciences Inc | 150K | ±0% | $21.3M | 1.3% |
VRTXVertex Pharmaceuticals Inc | 40K | ±0% | $20.9M | 1.3% |
ORICOric Pharmaceuticals, Inc. | 1.7M | −10.5% | $20.2M | 1.2% |
BBIOBridgeBio Pharma, Inc. | 300K | +9.1% | $19.7M | 1.2% |
INCYIncyte Corp | 160K | New | $19.4M | 1.2% |
DFTXDefinium Therapeutics, Inc. | 500K | −9.1% | $19M | 1.2% |
BTSGBrightSpring Health Services, Inc. | 325K | −40.9% | $18.4M | 1.1% |
ONCBeOne Medicines Ltd. | 50K | New | $18.3M | 1.1% |
ROIVRoivant Sciences Ltd. | 2M | ±0% | $18.3M | 1.1% |
LBRXLB Pharmaceuticals Inc | 470K | +213.3% | $18M | 1.1% |
BDXBecton Dickinson & Co | 100K | New | $17.9M | 1.1% |
BSXBoston Scientific Corp | 400K | −55.6% | $17.5M | 1.1% |
EWEdwards Lifesciences Corp | 200K | −68.0% | $17.3M | 1% |
ERASErasca, Inc. | 1.1M | +13.0% | $16.6M | 1% |
ALKSAlkermes plc. | 375K | +275.0% | $15.2M | 0.9% |
MDTMedtronic plc | 175K | −12.5% | $15.1M | 0.9% |
GKOSGlaukos Corp | 90K | −40.0% | $14.8M | 0.9% |
EHCEncompass Health Corp | 120K | New | $14.6M | 0.9% |
NVSNovartis AG | 100K | −50.0% | $14.3M | 0.9% |
ABSIAbsci Corp | 1.3M | +62.5% | $14M | 0.8% |
DGXQuest Diagnostics Inc | 55K | −72.5% | $12.8M | 0.8% |
ANROAlto Neuroscience, Inc. | 500K | ±0% | $12.8M | 0.8% |
MDGLMadrigal Pharmaceuticals, Inc. | 25K | ±0% | $12.6M | 0.8% |
BMYBristol Myers Squibb Co | 200K | New | $12.5M | 0.8% |
| 300K | New | $12.2M | 0.7% | |
QUREuniQure N.V. | 500K | −44.4% | $12.1M | 0.7% |
RYTMRhythm Pharmaceuticals, Inc. | 250K | −54.5% | $11.9M | 0.7% |
TEVATeva Pharmaceutical Industries Ltd | 300K | New | $11.9M | 0.7% |
TVTXTravere Therapeutics, Inc. | 200K | −46.7% | $11.8M | 0.7% |
PRAXPraxis Precision Medicines, Inc. | 40K | ±0% | $11.6M | 0.7% |
LIVANOVA PLCNOTE 2.500% 3/1 | 150K | New | $11.5M | 0.7% |
WATWaters Corp | 25K | −37.5% | $11M | 0.7% |
SRZNSurrozen, Inc. | 325K | New | $10.5M | 0.6% |
INSPInspire Medical Systems, Inc. | 150K | +50.0% | $10.4M | 0.6% |
MLYSMineralys Therapeutics, Inc. | 400K | −11.1% | $10.1M | 0.6% |
TYRATyra Biosciences, Inc. | 455K | New | $10M | 0.6% |
TMOThermo Fisher Scientific Inc. | 14K | New | $9.5M | 0.6% |
RGNXRegenxbio Inc. | 1.2M | +50.0% | $9M | 0.5% |
SYRESpyre Therapeutics, Inc. | 325K | ±0% | $8.9M | 0.5% |
OVIDOvid Therapeutics Inc. | 3.5M | New | $8.7M | 0.5% |
COOCooper Companies, Inc. | 150K | New | $8.5M | 0.5% |
CLYMClimb Bio, Inc. | 700K | New | $8M | 0.5% |
ATTOAttovia Therapeutics, Inc. | 450K | New | $7.7M | 0.5% |
ALNYAlnylam Pharmaceuticals, Inc. | 30K | New | $7.4M | 0.4% |
FTHFaeth Therapeutics, Inc. | 240K | New | $7.1M | 0.4% |
GHGuardant Health, Inc. | 40K | New | $7.1M | 0.4% |
TGTXTG Therapeutics, Inc. | 125K | New | $7M | 0.4% |
IONSIonis Pharmaceuticals Inc | 150K | New | $6.7M | 0.4% |
VORVor Biopharma Inc. | 350K | New | $6.7M | 0.4% |
COGTCogent Biosciences, Inc. | 200K | ±0% | $6.4M | 0.4% |
TXG10x Genomics, Inc. | 70K | New | $6.3M | 0.4% |
HELPHelus Pharma Inc. | 500K | New | $6.1M | 0.4% |
IMTXImmatics N.V. | 690K | New | $6.1M | 0.4% |
SANASana Biotechnology, Inc. | 2M | ±0% | $5.8M | 0.4% |
CMPSCOMPASS Pathways plc | 460K | New | $5.7M | 0.3% |
NGNENeurogene Inc. | 200K | New | $5.6M | 0.3% |
ALMSAlumis Inc. | 700K | ±0% | $5.2M | 0.3% |
ABVXAbivax S.A. | 50K | New | $5M | 0.3% |
APMDApnimed, Inc. | 225K | New | $4.9M | 0.3% |
BEAMBeam Therapeutics Inc. | 200K | −33.3% | $4.9M | 0.3% |
IVAInventiva S.A. | 1.3M | −14.5% | $4.8M | 0.3% |
CTNMContineum Therapeutics, Inc. | 345K | New | $4.6M | 0.3% |
ELVNEnliven Therapeutics, Inc. | 100K | −33.3% | $4.6M | 0.3% |
BHVNBiohaven Ltd. | 300K | −57.1% | $4M | 0.2% |
IDYAIDEAYA Biosciences, Inc. | 100K | ±0% | $3.8M | 0.2% |
TARAProtara Therapeutics, Inc. | 1.3M | −16.7% | $3.8M | 0.2% |
NRIXNurix Therapeutics, Inc. | 160K | New | $3.8M | 0.2% |
GLUEMonte Rosa Therapeutics, Inc. | 300K | New | $3.6M | 0.2% |
KARDKardigan, Inc. | 225K | +12.5% | $3.3M | 0.2% |
SVRASavara Inc | 600K | ±0% | $3.1M | 0.2% |
CAICaris Life Sciences, Inc. | 100K | New | $3.1M | 0.2% |
TRVITrevi Therapeutics, Inc. | 200K | ±0% | $2.9M | 0.2% |
IKTInhibikase Therapeutics, Inc. | 1.4M | ±0% | $2.8M | 0.2% |
MAZEMaze Therapeutics, Inc. | 100K | New | $2.7M | 0.2% |
AGMBAgomAb Therapeutics NV | 235K | New | $2.6M | 0.2% |
ETRAElectra Therapeutics, Inc. | 200K | New | $2.3M | 0.1% |
BRVEBraveheart Bio, Inc. | 100K | New | $2M | 0.1% |
CAMPCamp4 Therapeutics Corp | 495K | New | $2M | 0.1% |
ACRSAclaris Therapeutics, Inc. | 200K | New | $1.1M | 0.1% |
XFORX4 Pharmaceuticals, Inc | 250K | New | $725K | 0.1% |